You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic myeloid leukemia in chronic phase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ponatinib in CML Patients in Chronic Phase

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Therapeutic drug monitoring
  • Molecular Response
  • Cagliari, Italy
  • +4 more
Nov 3, 2023

Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Jena, Germany
      University Hospital Jena
    Jan 17, 2023

    Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Dasatinib Pill
    • Ketoconazole Pill
    • Monterrey, Nuevo Leon, Mexico
      Hospital Universitario Dr. José Eleuterio González
    Nov 25, 2022

    Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • +3 more
    • Augusta, Georgia
    • +1 more
    Jul 14, 2022

    "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

    Not yet recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Sohag, Egypt
        Sohag University Hospital
      Sep 14, 2022

      Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

      Recruiting
      • Olverembatinib
      • +2 more
      • Shenzhen, Guangdong, China
        Shenzhen Second People's Hospital
      Jul 26, 2022

      Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

      Completed
      • Chronic Myeloid Leukemia
        • East Hanover, New Jersey
          Novartis
        Nov 20, 2023

        Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

        Not yet recruiting
        • Chronic Myelogenous Leukemia - Chronic Phase
        • APN and medical management
        • +3 more
        • Avignon, Provence-Alpes-Côte d'Azur, France
          Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
        Oct 13, 2023

        Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Withdrawal;Drug
        • Imatinib withdrawal
        • +2 more
        • Brno, Czechia
        • +7 more
        Aug 24, 2022

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

        Recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 31, 2022

        Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

        Recruiting
        • Chronic Myeloid Leukemia in Myeloid Blast Crisis
        • +3 more
        • based decitabine and olverembatinib（HQP1351)chemotherapy
        • Guanzhou, China
          Department of Hematology, Nanfang Hospital, Southern Medical Uni
        Dec 6, 2022

        Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

        Recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Nilotinib
        • Shenzhen, Guangdong, China
          Shenzhen Second People's Hospital
        Mar 15, 2022

        CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

        Recruiting
        • CML
        • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
        • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
          FUNDALEU
        Jun 29, 2023

        MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

        Not yet recruiting
        • Myelodysplastic Syndromes
        • +3 more
        • Subcutaneous azacitidine
        • Oral decitabine/cedazuridine
        • Newcastle, New South Wales, Australia
          Calvary Mater Newcastle
        May 29, 2023

        CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

        Recruiting
        • CML, Chronic Phase
        • CML, Accelerated Phase
        • HS-10382(Part 1: Dose escalation)
        • HS-10382(Part 2: Dose expansion)
        • Wuhan, Hubei, China
          Union Hospital affiliated to Tongji Medical College of Huazhong
        Jan 12, 2023

        Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

        Active, not recruiting
        • Chronic Myeloid Leukemia, Chronic Phase
        • Beijing, China
          Peking University People's Hospital(北京大学人民医院)
        Jan 3, 2022

        Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

        Recruiting
        • Myelofibrosis
        • +2 more
        • Charlottesville, Virginia
          Danyelle Coley
        Jan 18, 2023

        Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

        Not yet recruiting
        • Myelodysplastic Syndrome
        • +4 more
        • UAE Inhibitor TAK-243
        • (no location specified)
        Oct 20, 2022

        Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 11, 2022

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

        Active, not recruiting
        • Acute Myeloid Leukemia
        • +9 more
        • Los Angeles, California
        • +5 more
        Jan 27, 2023

        Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

        Recruiting
        • Acute Biphenotypic Leukemia
        • +13 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 19, 2023

        Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

        Not yet recruiting
        • Chronic Myelogenous Leukemia
        • Houston, Texas
          The University of Texas MD Anderson Cancer Center
        Oct 12, 2023

        Metabolic Alternation and Clinicohematological Characteristic in

        Not yet recruiting
        • CML, Chronic Phase
        • Tyrosine kinase inhibitor
        • (no location specified)
        Nov 6, 2023

        Flumatinib, Chronic Myeloid Leukemia, Chronic Phase, Imatinib Trial in Shenzhen (Flumatinib)

        Recruiting
        • Flumatinib
        • +2 more
        • Shenzhen, Guangdong, China
          The Second People's Hospital of Shenzhen
        Mar 15, 2022

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +2 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jun 15, 2022